942 Should second TUR be performed in the first 2–6 weeks after the initial TUR necessarily in high risk non-muscle invasive bladder cancer patients receiving maintanance BCG? Multicenter trial of Turkish Society of Urooncology

Autor:	Ilker Tinay, C. Can, Güven Aslan, Mehmet İlker Gökçe, Murat Bozlu, Sümer Baltaci, Levent Türkeri, N.A. Mungan, A. Yıldırm
Rok vydání:	2015
Předmět:	medicine.medical_specialty Bladder cancer Turkish business.industry Urology Multicenter trial language Medicine Non muscle invasive business medicine.disease language.human_language Surgery
Zdroj:	European Urology Supplements. 14:e942-e942a
ISSN:	1569-9056
DOI:	10.1016/s1569-9056(15)60930-7
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3e523c2fbce7e1a8fba351230cbcd945 https://doi.org/10.1016/s1569-9056(15)60930-7 Zobrazit plný text záznamu Full Text from ScienceDirect